Showing results (1331-1340 of 1,456) with videos related to
Sort By:
Pageof 146
Heart Rhythm|September 17, 2021
Effect of electrode size and spacing on electrograms: Optimized electrode configuration for near-field electrogram characterizationMasateru Takigawa, Takeshi Kitamura, Shubhayu Basu, et al.Journal of Cardiovascular Electrophysiology|October 27, 2017
Atrial tachycardias: Cause or effect with ablation of persistent atrial fibrillation?Seigo Yamashita, Darren A Hooks, Ashok Shah, et al.Chest|February 4, 2015
Integration of palliative care in the context of rapid response: a report from the Improving Palliative Care in the ICU advisory boardJudith E Nelson, Kusum S Mathews, David E Weissman, et al.Stroke|September 30, 2025
Artificial Intelligence and Novel Trial Designs for Acute Ischemic Stroke: Opportunities and ChallengesJoseph P Broderick, Eva A Mistry, Paul M Wechsler, et al.Heart Rhythm|August 12, 2017
Electrogram signature of specific activation patterns: Analysis of atrial tachycardias at high-density endocardial mappingAntonio Frontera, Masateru Takigawa, Ruairidh Martin, et al.JAMA Neurology|February 9, 2024
Time to Anticoagulation Reversal and Outcomes After Intracerebral HemorrhageKevin N Sheth, Nicole Solomon, Brooke Alhanti, et al.Heart Rhythm|October 31, 2017
Revisiting anatomic macroreentrant tachycardia after atrial fibrillation ablation using ultrahigh-resolution mapping: Implications for ablationMasateru Takigawa, Nicolas Derval, Antonio Frontera, et al.Circulation. Arrhythmia and Electrophysiology|November 26, 2019
Does Ventricular Tachycardia Ablation Targeting Local Abnormal Ventricular Activity Elimination Reduce Ventricular Fibrillation Incidence?Takeshi Kitamura, Philippe Maury, Anna Lam, et al.Heart Rhythm|November 11, 2022
High-resolution mapping of reentrant atrial tachycardias: Relevance of low bipolar voltageF Daniel Ramirez, Marianna Meo, Corentin Dallet, et al.Cancer|July 4, 2025
Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800)Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera, et al.Pageof 146